Utah Medical Products Inc (UTMD)
EBITDA Growth
-36.92%
Quarterly · Period ending:
UTMD EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-36.92%period ending
Latest reported-36.92%period ending
UTMD Quarterly EBITDA YoY % (47.06% → -36.92%)
Year-over-year change
High-resolution chart · PNG
UTMD ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -36.9177% | |
| -7.5931% | |
| -3.2775% | |
| -17.097% | |
| -6.3214% | |
| -21.2338% | |
| -29.1814% | |
| -25.0838% | |
| -29.449% | |
| -19.5856% | |
| -24.6663% | |
| -7.3123% | |
| -0.3441% | |
| 4.3067% | |
| 8.1877% | |
| 1.3883% | |
| 4.5884% | |
| 10.5318% | |
| 13.711% | |
| 29.6289% | |
| 77.4142% | |
| 1.0217% | |
| -6.4372% | |
| -12.5284% | |
| -40.3049% | |
| 2.086% | |
| 30.5979% | |
| 20.3751% | |
| 8.4008% | |
| -3.1353% | |
| -6.2806% | |
| -4.7628% | |
| 1.5382% | |
| 6.3345% | |
| 22.4781% | |
| 16.1409% | |
| 13.2647% | |
| 6.8474% | |
| -6.3013% | |
| -3.5632% | |
| 6.2921% | |
| 8.6199% | |
| -7.5419% | |
| -1.1127% | |
| -3.2376% | |
| -0.6195% | |
| 12.2006% | |
| 8.8849% | |
| 9.0849% | |
| -0.0427% | |
| 2.0562% | |
| -6.6206% | |
| 2.997% | |
| -5.0872% | |
| 14.5212% | |
| 9.0224% | |
| 6.8704% | |
| 103.7159% | |
| 53.9267% | |
| 81.8862% | |
| 74.5625% | |
| -0.7377% | |
| -9.0476% | |
| -4.824% | |
| -0.594% | |
| -6.226% | |
| 15.8744% | |
| -18.1553% | |
| -17.2402% | |
| -3.1994% | |
| -15.3127% | |
| 7.9665% | |
| -0.6974% | |
| -5.4187% | |
| -4.069% | |
| -1.2422% | |
| -0.5203% | |
| 1.9369% | |
| 24.0376% | |
| 31.5479% | |
| 9.1219% | |
| 2.1245% | |
| -5.8397% | |
| -19.8326% | |
| -6.5771% | |
| -4.5121% | |
| -12.5088% | |
| -6.4033% | |
| -4.4917% | |
| -3.7698% | |
| -2.5412% | |
| -3.8953% | |
| 1.578% | |
| 4.9082% | |
| -43.2469% | |
| 6.5574% | |
| 2.3885% | |
| 3.8885% | |
| 87.8799% | |
| 6.3822% |